Renal failure related to fibrates administration (n = 46)

Nefrologia. 2017 Mar-Apr;37(2):216-217. doi: 10.1016/j.nefro.2016.09.013. Epub 2016 Nov 5.

[Article in English, Spanish]

Authors

Carmen R Cobelo Casas¹, Beatriz Millán Díaz², Lourdes González Tabarés², Nerea Gómez Larrambe², Luísa Cabezas González², María Luísa García Merino², Jesús Calviño Varela²

Affiliations

¹ Servicio de Nefrología, Hospital Universitario Lucus Augusti, Lugo, España. Electronic address: carmen.raquel.cobelo.casas@sergas.es.
² Servicio de Nefrología, Hospital Universitario Lucus Augusti, Lugo, España.

PMID: 27825656
DOI: 10.1016/j.nefro.2016.09.013

No abstract available

Publication types

Letter

MeSH terms

Aged
Female
Fenofibrate / adverse effects*
Humans
Hypolipidemic Agents / adverse effects*
Male
Renal Insufficiency / chemically induced*

Substances

Hypolipidemic Agents
Fenofibrate